1
|
Facente SN, Humphrey JL, Akiba C, Patel SV, Wenger LD, Tookes H, Bluthenthal RN, LaKosky P, Prohaska S, Morris T, Kral AH, Lambdin BH. Funding and Delivery of Syringe Services Programs in the United States, 2022. Am J Public Health 2024; 114:435-443. [PMID: 38478864 PMCID: PMC10937606 DOI: 10.2105/ajph.2024.307583] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/06/2024] [Indexed: 03/17/2024]
Abstract
Objectives. To describe the current financial health of syringe services programs (SSPs) in the United States and to assess the predictors of SSP budget levels and associations with delivery of public health interventions. Methods. We surveyed all known SSPs operating in the United States from February to June 2022 (n = 456), of which 68% responded (n = 311). We used general estimating equations to assess factors influencing SSP budget size and estimated the effects of budget size on multiple measures of SSP services. Results. The median SSP annual budget was $100 000 (interquartile range = $20 159‒$290 000). SSPs operating in urban counties and counties with higher levels of opioid overdose mortality had significantly higher budget levels, while SSPs located in counties with higher levels of Republican voting in 2020 had significantly lower budget levels. SSP budget levels were significantly and positively associated with syringe and naloxone distribution coverage. Conclusions. Current SSP funding levels do not meet minimum benchmarks. Increased funding would help SSPs meet community health needs. Public Health Implications. Federal, state, and local initiatives should prioritize sustained SSP funding to optimize their potential in addressing multiple public health crises. (Am J Public Health. 2024;114(4):435-443. https://doi.org/10.2105/AJPH.2024.307583).
Collapse
Affiliation(s)
- Shelley N Facente
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Jamie L Humphrey
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Christopher Akiba
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Sheila V Patel
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Lynn D Wenger
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Hansel Tookes
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Ricky N Bluthenthal
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Paul LaKosky
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Stephanie Prohaska
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Terry Morris
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Alex H Kral
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| | - Barrot H Lambdin
- Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA
| |
Collapse
|
2
|
Mundo Ortiz A, Nasri B. Socio-demographic determinants of COVID-19 vaccine uptake in Ontario: Exploring differences across the Health Region model. Vaccine 2024; 42:2106-2114. [PMID: 38413281 DOI: 10.1016/j.vaccine.2024.02.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Revised: 02/11/2024] [Accepted: 02/14/2024] [Indexed: 02/29/2024]
Abstract
The COVID-19 pandemic continues to be a worldwide public health concern. Although vaccines against this disease were rapidly developed, vaccination uptake has not been equal across all the segments of the population, particularly in the case of underrepresented groups. However, there are also differences in vaccination across geographical areas, which might be important to consider in the development of future public health vaccination policies. In this study, we examined the relationship between vaccination status (having received the first dose of a COVID-19 vaccine), socio-economic strata, and the Health Regions for individuals in Ontario, Canada. Our results show that between October of 2021 and January of 2022, individuals from underrepresented communities were three times less likely to be vaccinated than White/Caucasian individuals across the province of Ontario, and that in some cases, within these groups, individuals in low-income brackets had significantly higher odds of vaccination when compared to their peers in high income brackets. Finally, we identified significantly lower odds of vaccination in the Central, East and West Health Regions of Ontario within certain underrepresented groups. This study shows that there is an ongoing need to better understand and address differences in vaccination uptake across diverse segments of the population of Ontario that the pandemic has largely impacted.
Collapse
Affiliation(s)
- Ariel Mundo Ortiz
- Centre de Recherches Mathématiques, Université de Montréal. 2920 Ch de la Tour, Montréal, QC H3T 1N8, Canada; Department of Social and Preventive Medicine, École de Santé Publique, Université de Montréal. 7101 Av du Parc, Montréal, QC H3N 1X9, Canada; Centre de recherche en santé publique, Université de Montréal. 7101 Av du Parc, Montréal, QC H3N 1X9, Canada
| | - Bouchra Nasri
- Centre de Recherches Mathématiques, Université de Montréal. 2920 Ch de la Tour, Montréal, QC H3T 1N8, Canada; Department of Social and Preventive Medicine, École de Santé Publique, Université de Montréal. 7101 Av du Parc, Montréal, QC H3N 1X9, Canada; Centre de recherche en santé publique, Université de Montréal. 7101 Av du Parc, Montréal, QC H3N 1X9, Canada.
| |
Collapse
|
4
|
Yang TC, Shoff C, Choi SWE, Sun F. Multiscale dimensions of county-level disparities in opioid use disorder rates among older Medicare beneficiaries. Front Public Health 2022; 10:993507. [PMID: 36225787 PMCID: PMC9548636 DOI: 10.3389/fpubh.2022.993507] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Accepted: 09/07/2022] [Indexed: 01/26/2023] Open
Abstract
Background Opioid use disorder (OUD) among older adults (age ≥ 65) is a growing yet underexplored public health concern and previous research has mainly assumed that the spatial process underlying geographic patterns of population health outcomes is constant across space. This study is among the first to apply a local modeling perspective to examine the geographic disparity in county-level OUD rates among older Medicare beneficiaries and the spatial non-stationarity in the relationships between determinants and OUD rates. Methods Data are from a variety of national sources including the Centers for Medicare & Medicaid Services beneficiary-level data from 2020 aggregated to the county-level and county-equivalents, and the 2016-2020 American Community Survey (ACS) 5-year estimates for 3,108 contiguous US counties. We use multiscale geographically weighted regression to investigate three dimensions of spatial process, namely "level of influence" (the percentage of older Medicare beneficiaries affected by a certain determinant), "scalability" (the spatial process of a determinant as global, regional, or local), and "specificity" (the determinant that has the strongest association with the OUD rate). Results The results indicate great spatial heterogeneity in the distribution of OUD rates. Beneficiaries' characteristics, including the average age, racial/ethnic composition, and the average hierarchical condition categories (HCC) score, play important roles in shaping OUD rates as they are identified as primary influencers (impacting more than 50% of the population) and the most dominant determinants in US counties. Moreover, the percentage of non-Hispanic white beneficiaries, average number of mental health conditions, and the average HCC score demonstrate spatial non-stationarity in their associations with the OUD rates, suggesting that these variables are more important in some counties than others. Conclusions Our findings highlight the importance of a local perspective in addressing the geographic disparity in OUD rates among older adults. Interventions that aim to reduce OUD rates in US counties may adopt a place-based approach, which could consider the local needs and differential scales of spatial process.
Collapse
Affiliation(s)
- Tse-Chuan Yang
- Department of Sociology, University at Albany, State University of New York, Albany, NY, United States
| | - Carla Shoff
- Independent Consultant, Baltimore, MD, United States
| | - Seung-won Emily Choi
- Department of Sociology, Anthropology, and Social Work, Texas Tech University, Lubbock, TX, United States
| | - Feinuo Sun
- Global Aging and Community Initiative, Mount Saint Vincent University, Halifax, NS, Canada
| |
Collapse
|